Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 5/20 | 0.72 |
| ▸ | SLC1A2 | P43004 | 5/20 | 0.72 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.72 |
| ▸ | GRM8 | O00222 | 2/20 | 0.72 |
| ▸ | GRM6 | O15303 | 2/20 | 0.72 |
| ▸ | GRM7 | Q14831 | 2/20 | 0.72 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.72 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.72 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.72 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.72 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.72 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.72 |
| ▸ | GSR | P00390 | 1/20 | 0.72 |
| ▸ | GRM5 | P41594 | 1/20 | 0.72 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.72 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.72 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.72 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.72 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| D-Glutamate SCHEMBL9176409 | 1.00 | SLC1A3 (0.72) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 | |
| Glutamic Acid SCHEMBL1126187 | 1.00 | SLC1A3 (0.72) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 | |
| Glutamic Acid SCHEMBL5614072 | 1.00 | SLC1A3 (0.72) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 | |
| Glutamic Acid SCHEMBL6130437 | 1.00 | SLC1A3 (0.72) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 | |
| Glutamic Acid SCHEMBL24357 | 1.00 | SLC1A3 (0.72) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 | |
| D-Glutamate SCHEMBL19876607 | 0.96 | SLC1A3 (0.67) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 | |
| Glutamic Acid SCHEMBL17926909 | 0.96 | SLC1A3 (0.67) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 | |
| Glutamic Acid SCHEMBL1365479 | 0.96 | SLC1A3 (0.67) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 | |
| Glutamic Acid SCHEMBL18249491 | 0.94 | SLC1A3 (0.64) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 | |
| Glutamic Acid SCHEMBL429944 | 0.94 | SLC1A3 (0.64) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1084137-A1 | PEPTIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) | 2001-03-21 | — | — | EP | claimed |
| EP-0514509-B1 | COMPOSITION AND ITS PREPARATION PROCESS USING ANTIGEN CONJUGATED TO ENZYMATIC ACTIVITY FOR IMMUNOLOGICAL DIAGNOSIS AND CHAGAS' DISEASE IMMUNOLOGICAL DIAGNOSIS KITS, FOR INDIVIDUAL AND EPIDEMIOLOGICAL APPLICATION, BASED ON THAT COMPOSITION | FUNDACAO OSWALDO CRUZ (BR) | 2000-09-20 | — | — | EP | claimed |
| WO-1999064442-A1 | PEPTIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI S.P.A. (IT) | 1999-12-16 | — | — | WO | claimed |
| CN-117157094-A | Pharmaceutical composition for preventing or treating chronic kidney disease comprising glucagon derivative | 韩美药品株式会社 | 2023-12-01 | — | — | CN | disclosed |
| US-20230227520-A1 | NOVEL G-CSF MIMICS AND THEIR APPLICATIONS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-07-20 | — | — | US | disclosed |
| EP-4076651-A1 | NOVEL G-CSF MIMICS AND THEIR APPLICATIONS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2022-10-26 | — | — | EP | disclosed |
| CN-113166334-A | Amino acid grafted polymers with smoke handling properties | 雅富顿化学公司 | 2021-07-23 | — | — | CN | disclosed |
| WO-2021123033-A1 | NOVEL G-CSF MIMICS AND THEIR APPLICATIONS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-06-24 | — | — | WO | disclosed |
| US-10175233-B2 | Biomarkers for cardiovascular diseases and methods using the same | METABOLON, INC. (US) | 2019-01-08 | — | — | US | disclosed |
| US-20160178620-A1 | Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and other Metabolic-Syndrome Related Disorders and Methods Using the Same | METABOLON, INC. | 2016-06-23 | — | — | US | disclosed |
| WO-2016048828-A1 | GENETICALLY MODIFIED MICROBES FOR THE BIOLOGICAL CONVERSION OF CARBONACEOUS MATERIALS TO ISOBUTANOL AND ISOAMYL ALCOHOL | CIRIS ENERGY, INC. (US) | 2016-03-31 | — | — | WO | disclosed |
| WO-2004081025-A2 | DIFFERENTIAL MEGAPLEX IMMUNOASSAY | TCP INNOVATIONS LIMITED (GB) | 2004-09-23 | — | — | WO | disclosed |
| EP-1355628-A2 | STABILISED POLYMERIC AEROSOLS FOR PULMONARY GENE DELIVERY | Board of Regents, The University of Texas System (US) | 2003-10-29 | — | — | EP | disclosed |
| EP-1322337-A2 | PEI : DNA VECTOR FORMULATIONS FOR IN VITRO AND IN VIVO GENE DELIVERY | Board of Regents, The University of Texas System (US) | 2003-07-02 | — | — | EP | disclosed |
| US-20020187105-A1 | Polymer combinations that result in stabilized aerosols for gene delivery to the lungs | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2002-12-12 | — | — | US | disclosed |
| US-20020151060-A1 | PEI: DNA vector formulations for in vitro and in vivo gene delivery | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2002-10-17 | — | — | US | disclosed |
| WO-2002060412-A2 | STABILISED POLYMERIC AEROSOLS FOR PULMONARY GENE DELIVERY | BOARD OF REGENTS (US) | 2002-08-08 | — | — | WO | disclosed |
| WO-2002024232-A2 | PEI: DNA VECTOR FORMULATIONS FOR IN VITRO AND IN VIVO GENE DELIVERY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-03-28 | — | — | WO | disclosed |
| EP-0514509-B1 | COMPOSITION AND ITS PREPARATION PROCESS USING ANTIGEN CONJUGATED TO ENZYMATIC ACTIVITY FOR IMMUNOLOGICAL DIAGNOSIS AND CHAGAS' DISEASE IMMUNOLOGICAL DIAGNOSIS KITS, FOR INDIVIDUAL AND EPIDEMIOLOGICAL APPLICATION, BASED ON THAT COMPOSITION | FUNDACAO OSWALDO CRUZ (BR) | 2000-09-20 | — | — | EP | disclosed |
| US-4351337-A | Biodegradable, implantable drug delivery device, and process for preparing and using the same | ARTHUR D. LITTLE, INC. (US) | 1982-09-28 | — | — | US | disclosed |